Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-23-010190

Options or other derivatives

  • Chief Commercial Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Simon Farrell · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-16 Grant or award : show line 1 in the form Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X03/doc4.xml…